Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents

• Dong Wha Jun ,

  Contributed equally to this work with: Dong Wha Jun, Mihwa Hwang

  Affiliation New Experimental Therapeutics Branch, Division of Convergence Technology, National Cancer Centre, Goyang, Gyeonggi, Korea

  ⨯
• Mihwa Hwang ,

  Contributed equally to this work with: Dong Wha Jun, Mihwa Hwang

  Affiliation New Experimental Therapeutics Branch, Division of Convergence Technology, National Cancer Centre, Goyang, Gyeonggi, Korea

  ⨯
• Hyun Jung Kim,

  Affiliation New Experimental Therapeutics Branch, Division of Convergence Technology, National Cancer Centre, Goyang, Gyeonggi, Korea

  ⨯
• Soo Kyung Hwang,

  Affiliation Cancer Cell and Molecular Biology Branch, Division of Cancer Biology, National Cancer Centre, Goyang, Gyeonggi, Korea

  ⨯
• Sunshin Kim ,

  * E-mail: ksunshin@ncc.re.kr (SK); chlee@ncc.re.kr (CHL)

  Affiliation New Experimental Therapeutics Branch, Division of Convergence Technology, National Cancer Centre, Goyang, Gyeonggi, Korea

  ⨯
• Chang-Hun Lee

  * E-mail: ksunshin@ncc.re.kr (SK); chlee@ncc.re.kr (CHL)

  Affiliation Cancer Cell and Molecular Biology Branch, Division of Cancer Biology, National Cancer Centre, Goyang, Gyeonggi, Korea

  ⨯